Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Extended-Release in Jail and at Re-Entry
NCT03604159Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine in opioid use disorder (OUD), sponsored by NYU Langone Health. Started Jun 2019; status: completed.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03604159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604159.